AI Article Synopsis
- The study focuses on the challenges of managing optic pathway gliomas (OPGs) in children, emphasizing the innovative approach of using gastrin-releasing peptide receptor (GRPR)-targeted PET imaging.
- Eight children with suspected OPGs underwent PET/MRI imaging, which revealed high uptake of Ga-NOTA-Aca-BBN(7-14) in all lesions, offering better contrast compared to traditional methods.
- The findings suggest that this imaging technique is effective for accurately identifying and delineating OPGs, and it shows a correlation between the PET imaging results and the expression of GRPR in the tumors.
Article Abstract
Purpose: Optic pathway glioma (OPG) is a rare neoplasm that arises predominantly during childhood. Its location in a sensitive region involving the optic pathways, onset in young patients and controversial therapy choice make the management of OPG a challenge in paediatric neuro-oncology. In this study we assessed gastrin-releasing peptide receptor (GRPR)-targeted positron emission tomography (PET) imaging in children with OPG, and the application of a PET/MRI imaging-guided surgery navigation platform.
Methods: Eight children (five boys, mean age 8.81 years, range 5-14 years) with suspicion of optic pathway glioma on MRI were recruited. Written informed consent was obtained from all patients and legal guardians. Brain PET/CT or PET/MRI acquisitions were performed 30 min after intravenous injection of 1.85 MBq/kg body weight of Ga-NOTA-Aca-BBN(7-14). Four patients also underwent F-FDG brain PET/CT for comparison. All patients underwent surgical resection within 1 week.
Results: All 11 lesions (100%) in the eight patients showed prominent Ga-NOTA-Aca-BBN(7-14) uptake with excellent contrast in relation to surrounding normal brain tissue. Tumour-to-background ratios (SUVmax and SUVmean) were significantly higher for Ga-NOTA-Aca-BBN(7-14) than for F-FDG (28.4 ± 5.59 vs. 0.47 ± 0.11 and 18.3 ± 4.99 vs. 0.35 ± 0.07, respectively). Fusion images for tumour delineation were obtained in all patients using the PET/MRI navigation platform. All lesions were pathologically confirmed as OPGs with positive GRPR expression, and 75% were pilocytic astrocytoma WHO grade I and 25% were diffuse astrocytoma WHO grade II. There was a positive correlation between the SUV of Ga-NOTA-Aca-BBN(7-14) and the expression level of GRPR (r = 0.56, P < 0.01, for SUVmax; r = 0.47, P < 0.05, for SUVmean).
Conclusion: This prospective study showed the feasibility of Ga-NOTA-Aca-BBN(7-14) PET in children with OPG for tumour detection and localization. Ga-NOTA-Aca-BBN(7-14) PET/MRI may be helpful for assisting surgery planning in OPG patients with severe symptoms, GRPR-targeted PET has the potential to provide imaging guidance for further GRPR-targeted therapy in patients with OPG.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00259-019-04392-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!